Recruiting Pneumonia Studies in Augusta
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to impro...
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in adult hospitalized subjects with sC...
About Pneumonia Clinical Trials in Augusta
Pneumonia is an infection that inflames the air sacs in one or both lungs, which may fill with fluid or pus. It can range from mild to life-threatening. Treatment depends on the cause and severity, including antibiotics, antivirals, and supportive care.
There are currently 2 pneumonia clinical trials recruiting participants in Augusta, GEORGIA. These studies are seeking a combined 20,590 participants. Research is being sponsored by UMC Utrecht, Biotest. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pneumonia Clinical Trials in Augusta — FAQ
Are there pneumonia clinical trials in Augusta?
Yes, there are 2 pneumonia clinical trials currently recruiting in Augusta, GEORGIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Augusta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.
Are clinical trials in Augusta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.
What pneumonia treatments are being tested?
The 2 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for pneumonia.
Data updated March 2, 2026 from ClinicalTrials.gov